Genprex to Present at Upcoming December Investor Conference
December 2, 2022
Todos Medical Terminates Tollovid(TM) Products License & Distribution Agreement with T-Cell Protect Hellas S.A.
November 10, 2022
Related Post
-
-
Silo Pharma Issues Letter to Shareholders Detailing Progress on Pipeline Assets Combining Traditional Therapeutics with Psychedelic Medicine
December 1, 2022
-
OncoSec Announces Pricing of $3.5 Million Public Offering
November 30, 2022
-
First Wave BioPharma Files Investigational New Drug Application for Enhanced Microgranule Delivery Formulation of Adrulipase
November 30, 2022